AIT THERAPEUTICS INC

Inactive Instrument

Analyst Reco. AIT Therapeutics Inc Other OTC

Equities

US50027L1070

End-of-day quote Other OTC Other stock markets
- ^USD	-

30/04	Truist Lowers Price Target on Beyond Air to $8 From $10, Keeps Buy Rating	MT
12/02	Beyond Air, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Truist Lowers Price Target on Beyond Air to $8 From $10, Keeps Buy Rating	30/04	MT
Truist Cuts Beyond Air's Price Target to $10 From $14, Maintains Buy Rating	14/11	MT
Piper Sandler Starts Beyond Air at Overweight With $10 Price Target	28/23/28	MT
Truist Adjusts Beyond Air's Price Target to $14 From $18, Keeps Buy Rating	21/23/21	MT
Roth MKM Cuts Beyond Air's Price Target to $12 From $14, Maintains Buy Rating	28/23/28	MT
Oppenheimer Cuts Beyond Air's Price Target to $10 From $16, Maintains Outperform Rating	23/23/23	MT
BTIG Research Initiates Coverage on Beyond Air With Buy Rating, $15 Price Target	15/23/15	MT
Oppenheimer Adjusts Beyond Air Price Target to $16 From $13, Maintains Outperform Rating	12/22/12	MT
Truist Securities Adjusts Beyond Air Price Target to $20 From $16, Maintains Buy Rating	29/22/29	MT
Ladenburg Thalmann Adjusts Beyond Air's Price Target to $23 From $17, Reiterates Buy Rating	29/22/29	MT
Oppenheimer Adjusts Beyond Air PT to $13 From $9, Maintains Outperform Rating	12/21/12	MT
Truist Securities Adjusts Beyond Air's Price Target to $16 From $12, Reiterates Buy Rating	12/21/12	MT
BEYOND AIR : Truist Securities Starts Beyond Air at Buy with $12 Price Target	28/21/28	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer